Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C.

Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C.

Hepatitis C virus (HCV) genotype 1 infections are significantly more difficult to eradicate with PEG-IFN/ribavirin therapy, compared to HCV genotype 2. The aim of this work is to investigate the difference of immunological impairments underlying this phenomenon. Pre-treatment NKG2D expression on per...

Full description

Bibliographic Details
Main Authors:	Po-sung Chu, Hirotoshi Ebinuma, Nobuhiro Nakamoto, Kazuo Sugiyama, Shingo Usui, Yuko Wakayama, Nobuhito Taniki, Akihiro Yamaguchi, Shunsuke Shiba, Yoshiyuki Yamagishi, Takaji Wakita, Toshifumi Hibi, Hidetsugu Saito, Takanori Kanai
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4428701?pdf=render

Similar Items

On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C.
by: Po-Sung Chu, et al.
Published: (2017-01-01)

Detection of bacterial DNA by in situ hybridization in patients with decompensated liver cirrhosis
by: Shingo Usui, et al.
Published: (2017-10-01)

Liver Fibrosis Markers Improve Prediction of Outcome in Non‐Acetaminophen‐Associated Acute Liver Failure
by: Aya Ugamura, et al.
Published: (2018-11-01)

Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an observational study
by: Shunsuke Shiba, et al.
Published: (2020-03-01)

Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis.
by: Hitomi Hoshi, et al.
Published: (2021-01-01)

CLIF‐C Organ Failure Score and Liver Volume Predict Prognosis in Steroid‐Treated Severe Acute Autoimmune Hepatitis
by: Akihiko Ikura, et al.
Published: (2020-07-01)

Dynamics of type IV collagen 7S fragment on eradication of HCV with direct antiviral agents: Prognostic and metabolomic impacts.
by: Karin Yamataka, et al.
Published: (2022-01-01)

Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 Fusion Proteins on Triple–Negative Breast Cancer
by: Polina Kaidun, et al.
Published: (2023-08-01)

Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.
by: Natasja Nielsen, et al.
Published: (2012-01-01)

The gut-liver axis in hepatobiliary diseases
by: Masataka Ichikawa, et al.
Published: (2024-01-01)

Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients.
by: Giulia Marchetti, et al.
Published: (2012-01-01)

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
by: Roberto J Carvalho-Filho, et al.
Published: (2010-03-01)

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas
by: Ilona Hagelstein, et al.
Published: (2021-04-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)

Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population
by: Mario Espinosa, et al.
Published: (2015-05-01)

Expression of NKG2D Receptors in CD3+ and CD56+ Cells in Blood Samples of Pre-eclampsia Patients and the Effect of Silymarin on Their Activity in Vitro
by: Ali Reza Andalib, et al.
Published: (2022-04-01)

Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells
by: Valentina Gentili, et al.
Published: (2023-07-01)

Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
by: Melanie Märklin, et al.
Published: (2019-05-01)

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
by: Gonçales Neiva SL, et al.
Published: (2010-07-01)

Macrophages and dendritic cells emerge in the liver during intestinal inflammation and predispose the liver to inflammation.
by: Yohei Mikami, et al.
Published: (2014-01-01)

KIR+CD8+ and NKG2A+CD8+ T cells are distinct innate-like populations in humans
by: Seong Jin Choi, et al.
Published: (2023-03-01)

Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation
by: J Shepherd, et al.
Published: (2007-03-01)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
by: Saleem Sana, et al.
Published: (2011-05-01)

NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus
by: Di Yang, et al.
Published: (2017-04-01)

NKG7 Enhances CD8+ T Cell Synapse Efficiency to Limit Inflammation
by: Emily J. Lelliott, et al.
Published: (2022-07-01)

Ocular manifestations in Egyptian children with chronic hepatitis C treated with pegylated interferon and ribavirin
by: Dalia H.A.R Khalil, et al.
Published: (2016-01-01)

Combined pegylated interferon and ribavirin for the management of chronic hepatitis C in a prison setting
by: Sergio Sabbatani, et al.

Functional dichotomy between NKG2D and CD28-mediated co-stimulation in human CD8+ T cells.
by: Kamalakannan Rajasekaran, et al.
Published: (2010-09-01)

Hepatic Adenosine Triphosphate Reduction Through the Short‐Chain Fatty Acids–Peroxisome Proliferator‐Activated Receptor γ–Uncoupling Protein 2 Axis Alleviates Immune‐Mediated Acute Hepatitis in Inulin‐Supplemented Mice
by: Akihiro Yamaguchi, et al.
Published: (2021-09-01)

Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study.
by: Helen Kovari, et al.
Published: (2015-01-01)

NKG2D⁺ IFN-γ⁺ CD8⁺ T cells are responsible for palladium allergy.
by: Mitsuko Kawano, et al.
Published: (2014-01-01)

NKG2D signaling certifies effector CD8 T cells for memory formation
by: Cynthia Perez, et al.
Published: (2019-02-01)

Expectoration of large bronchial casts secondary to the treatment of chronic hepatitis c with pegylated interferon and ribavirin
by: Evaldo Stanislau Affonso de Araújo, et al.
Published: (2010-01-01)

Alanine transaminase as a single marker is not reliable for selecting candidates of pegylated interferon and ribavirin treatment
by: Heidar Sharafi, et al.
Published: (2015-02-01)

Cutaneous Sarcoidosis: An Uncommon Side Effect of Pegylated Interferon and Ribavirin Use for Chronic Hepatitis C
by: Elson Vidal Martins Jr., et al.
Published: (2009-11-01)

Chronic hepatitis C successfully treated with telaprevir, pegylated interferon and ribavirin in severe aplastic anemia
by: Ilker I. Balkan, et al.
Published: (2014-11-01)

Thyroid disturbances in children treated with combined pegylated interferon-alpha and ribavirin for chronic hepatitis C
by: Yasser K. Rashed, et al.
Published: (2020-02-01)

Efficiency of Chronic Hepatitis C Therapy with Pegylated Interferon and Ribavirin using Microsoft SQL Server
by: Vasileios PAPACHRISTOS, et al.
Published: (2012-11-01)

Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patients
by: Stephen Weber, et al.
Published: (2024-02-01)

Enriched HLA-E and CD94/NKG2A interaction limits antitumor CD8+ tumor-infiltrating T lymphocyte responses
by: Abd Hamid, M, et al.
Published: (2019)